<!DOCTYPE html><html class="" lang="en"><head>
<!-- REQUIRED META INFORMATION -->
<meta charset="UTF-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
<meta name="viewport" content="width=device-width, initial-scale=1">

<meta name="DCTERMS:contentOwner" content="TNeville">
<meta name="DCTERMS:contentOffice" content="DCRDP:ODP:OMP">

<meta name="DCTERMS:coder" content="^ORDP Webmaster">
<meta name="DCTERMS:coderOffice" content="DCRDP:ODEPPIN:OPPS">

<meta name="description" content="102.00-SpecialSensesandSpeech-Childhood">
<meta name="DCTERMS:dateCertified" content="2019-11-25">
 
<!-- DOCUMENT TITLE -->
<title>102.00 Special Senses and Speech - Childhood | Disability | SSA</title>
 
    <!-- STYLES -->
<link rel="stylesheet" href="/framework/css/ssa.firefly.css">

<!-- SCRIPTS -->
<script async="" src="https://www.googletagmanager.com/gtm.js?id=GTM-5GQXH7Q"></script><script src="/framework/js/ssa.firefly.head.js"></script>


<script>(window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"SJ-86d8640c-26e8-4549-b53c-eceab2da1d48","rua.cook":"true","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);</script>
                              <script>!function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.close()}function a(e){window.BOOMR_onload=e&&e.timeStamp||(new Date).getTime()}if(!window.BOOMR||!window.BOOMR.version&&!window.BOOMR.snippetExecuted){window.BOOMR=window.BOOMR||{},window.BOOMR.snippetStart=(new Date).getTime(),window.BOOMR.snippetExecuted=!0,window.BOOMR.snippetVersion=12,window.BOOMR.url=n+"LERZW-HECFS-R8H4E-23UQ7-ERMQB";var i=document.currentScript||document.getElementsByTagName("script")[0],o=!1,r=document.createElement("link");if(r.relList&&"function"==typeof r.relList.supports&&r.relList.supports("preload")&&"as"in r)window.BOOMR.snippetMethod="p",r.href=window.BOOMR.url,r.rel="preload",r.as="script",r.addEventListener("load",e),r.addEventListener("error",function(){t(!0)}),setTimeout(function(){if(!o)t(!0)},3e3),BOOMR_lstart=(new Date).getTime(),i.parentNode.appendChild(r);else t(!1);if(window.addEventListener)window.addEventListener("load",a,!1);else if(window.attachEvent)window.attachEvent("onload",a)}}(),"".length>0)if(e&&"performance"in e&&e.performance&&"function"==typeof e.performance.setResourceTimingBufferSize)e.performance.setResourceTimingBufferSize();!function(){if(BOOMR=e.BOOMR||{},BOOMR.plugins=BOOMR.plugins||{},!BOOMR.plugins.AK){var n="false"=="true"?1:0,t="cookiepresent",a="im6jsaqxzx4y42inlmja-f-409b43aed-clientnsv4-s.akamaihd.net",i="false"=="true"?2:1,o={"ak.v":"39","ak.cp":"1204614","ak.ai":parseInt("728289",10),"ak.ol":"0","ak.cr":22,"ak.ipv":4,"ak.proto":"h3","ak.rid":"22a599a","ak.r":46716,"ak.a2":n,"ak.m":"dsca","ak.n":"essl","ak.bpcip":"67.60.153.0","ak.cport":62171,"ak.gh":"23.205.248.142","ak.quicv":"0x00000001","ak.tlsv":"tls1.3","ak.0rtt":"","ak.0rtt.ed":"","ak.csrc":"-","ak.acc":"","ak.t":"1762482962","ak.ak":"hOBiQwZUYzCg5VSAfCLimQ==04bBOBUdwALaPcXinO7o8YNH7ON+a22CrhPViUoWMhZvbe5PbYUQmr5AvgbquSzWxhssZhh9foBbUMEPwzjXMalOt+IDIYZ/30pxZqGUJPz7BnmlOpF+oRwDyZ1uB3qSXkA8u38AZRXiLc0qeDdvwB2GmRKjcPSJDvGJCqzOXZN4RcDlxw79R/ybVaNS4byocLtWgxw0bt5RSFUKXnuykYfslbdQLhH59lM6YGQMqRSkBmFgKhPNAEsECYKuhL6LQ8G/1tyxCmZwD76yKGBlLj8hk6wSlsH7HM9Eh9jZTar3u2FXBJbXtCKuyQktFuRW8J5D7mnH5B7GTcVifJvhx0IuNMFYeZG69G1/s7BSxx454WZ2sIkBBDgOUSrSPmAd3kFsxlqqMkb/CX3OdngTx1oK5k2LDYmSVkJGxqlc+RU=","ak.pv":"120","ak.dpoabenc":"","ak.tf":i};if(""!==t)o["ak.ruds"]=t;var r={i:!1,av:function(n){var t="http.initiator";if(n&&(!n[t]||"spa_hard"===n[t]))o["ak.feo"]=void 0!==e.aFeoApplied?1:0,BOOMR.addVar(o)},rv:function(){var e=["ak.bpcip","ak.cport","ak.cr","ak.csrc","ak.gh","ak.ipv","ak.m","ak.n","ak.ol","ak.proto","ak.quicv","ak.tlsv","ak.0rtt","ak.0rtt.ed","ak.r","ak.acc","ak.t","ak.tf"];BOOMR.removeVar(e)}};BOOMR.plugins.AK={akVars:o,akDNSPreFetchDomain:a,init:function(){if(!r.i){var e=BOOMR.subscribe;e("before_beacon",r.av,null,null),e("onbeacon",r.rv,null,null),r.i=!0}return this},is_complete:function(){return!0}}}}()}(window);</script><link href="https://s.go-mpulse.net/boomerang/LERZW-HECFS-R8H4E-23UQ7-ERMQB" rel="preload" as="script"><style>@font-face{font-family:"Public Sans Web";src:url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-Light.woff2) format("woff2"),url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-Light.woff) format("woff"),url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-Light.ttf) format("truetype");font-weight:300;font-style:normal;font-display:swap}@font-face{font-family:"Public Sans Web";src:url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-Regular.woff2) format("woff2"),url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-Regular.woff) format("woff"),url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-Regular.ttf) format("truetype");font-weight:400;font-style:normal;font-display:swap}@font-face{font-family:"Public Sans Web";src:url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-SemiBold.woff2) format("woff2"),url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-SemiBold.woff) format("woff"),url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-SemiBold.ttf) format("truetype");font-weight:600;font-style:normal;font-display:swap}@font-face{font-family:"Public Sans Web";src:url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-Bold.woff2) format("woff2"),url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-Bold.woff) format("woff"),url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-Bold.ttf) format("truetype");font-weight:700;font-style:normal;font-display:swap}@font-face{font-family:"Public Sans Web";src:url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-ExtraBold.woff2) format("woff2"),url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-ExtraBold.woff) format("woff"),url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-ExtraBold.ttf) format("truetype");font-weight:800;font-style:normal;font-display:swap}</style><meta property="og:site_name" content="Social Security"><meta property="og:type" content="website"><meta property="og:url" content="https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm"><meta property="og:title" content="102.00 Special Senses and Speech - Childhood | Disability | SSA"><meta property="og:description" content="102.00-SpecialSensesandSpeech-Childhood"><meta property="og:image:url" content="https://www.ssa.gov/themes/custom/ssa_core/logo.svg"><meta property="og:image:secure_url" content="https://www.ssa.gov/themes/custom/ssa_core/logo.svg"><meta property="og:image:alt" content="U.S. Social Security Administration"><meta property="og:locale" content="en_US"><meta property="og:locale:alternate" content="es_ES"><script id="boomr-scr-as" src="https://s.go-mpulse.net/boomerang/LERZW-HECFS-R8H4E-23UQ7-ERMQB" async=""></script></head>

<body style="margin: 0px;">
  <!-- BANNER -->
  <aside class="accessibility" id="accessibility"><a href="#content" id="skip-navigation">Skip to main content</a></aside>
<!-- WCMS SITE ALERT (EMERGENCY) -->
<div class="wsa" aria-label="Site Alert" data-type="emergency">
  <div class="wsag">
    <svg focusable="false" height="26" width="26" viewBox="0 0 20 20" aria-hidden="true">
      <path fill="#FFFFFF" fill-rule="evenodd" stroke-width="0" d="M10.8,15h-1.7v-1.7h1.7v1.7ZM10.8,11.7h-1.7v-4.9h1.7v4.9Z" vector-effect="non-scaling-stroke"></path>
      <path fill="#1C1D1F" fill-rule="evenodd" stroke-width="0" d="M.8,17.5h18.3L10,1.7.8,17.5ZM10.8,15h-1.7v-1.7h1.7v1.7ZM10.8,11.7h-1.7v-4.9h1.7v4.9h0Z" vector-effect="non-scaling-stroke"></path>
    </svg>
    <div>
      <a href="/myaccount/"><u>Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services.</u></a>
    </div>
  </div>
</div>
<!-- WCMS SITE ALERT (INFORMATION) -->
<div class="wsa" aria-label="Site Alert" data-type="information">
  <div class="wsag">
    <svg focusable="false" height="26" width="26" viewBox="0 0 20 20" aria-hidden="true">
      <path fill="#1C1D1F" fill-rule="evenodd" stroke-width="0" d="M10,1.7C5.4,1.7,1.7,5.4,1.7,10s3.7,8.3,8.3,8.3,8.3-3.7,8.3-8.3S14.6,1.7,10,1.7ZM9.2,7.5v-1.7h1.7v1.7h-1.7ZM9.2,9.2v5h1.7v-5h-1.7Z" vector-effect="non-scaling-stroke"></path>
      <path fill="#FFFFFF" fill-rule="evenodd" stroke-width="0" d="M10.8,7.5h-1.7v-1.7h1.7v1.7Z" vector-effect="non-scaling-stroke"></path>
      <path fill="#FFFFFF" fill-rule="evenodd" stroke-width="0" d="M10.8,14.2h-1.7v-5h1.7v5Z" vector-effect="non-scaling-stroke"></path>
    </svg>
    <div>
      <a href="https://www.ssa.gov/manage-benefits/get-benefit-letter"><u>Get a benefit verification letter.</u></a>
    </div>
  </div>
</div>
<ssa-header class="print-dn"></ssa-header><script src="https://www.ssa.gov/legacy/components/dist/ssa-header.js"></script>
  <!-- MAIN CONTENT -->
  <main class="content" id="content" role="main">
    <!-- TITLE BAR -->
    <section class="bg-ivory-200">
      <!-- WRAPPER -->
      <div class="py2 wrapper">
        <h2 class="fw4 ma0" id="Top">Medical/Professional Relations</h2>
        </div>
    </section>

    <!-- WRAPPER -->
    <section class="wrapper">
    
    <!--GRID-->
<div class="grid">
	
<!-- FIRST COLUMN -->
<article class="cell w-100 m-w-100">
	
<!-- BREADCRUMBS -->
<nav class="breadcrumbs fs1" aria-label="Breadcrumbs">
  <ol>
    <li><a href="https://www.ssa.gov">SSA Home</a></li>
	<li><a href="https://www.ssa.gov/disability">Disability</a></li>
	<li><a href="../index.htm">Medical/Professional Relations</a></li>
	<li><a href="index.htm">Disability Evaluation Under Social Security</a></li>
	<li><a href="ChildhoodListings.htm">Listing of Impairments - Child Listings (Part B)</a></li> 
    <li aria-current="page">102.00 Special Senses and Speech - Childhood</li>
  </ol>
</nav>
</article><!--END FIRST COLUMN-->

<!-- FIRST COLUMN -->
<article class="cell w-100 m-w-20">


<p class="js-toggle"><a href="AdultListings.htm">Adult Listings (Part A)</a></p>
<p class="js-toggle"><a href="ChildhoodListings.htm">Childhood Listings (Part B)</a></p>
<p class="js-toggle"><a href="general-info.htm">General Information</a></p>
<p class="js-toggle"><a href="evidentiary.htm">Evidentiary Requirements</a></p>
<p class="js-toggle"><a href="listing-impairments.htm">Listing of Impairments (overview) </a></p>

<p class="js-toggle"><a href="revisions-rules.html">Revisions to Rules Regarding the Evaluation of Medical Evidence</a></p>
                          </article><!-- END FIRST COLUMN-->

<!--SECOND COLUMN-->
<article class="cell w-100 m-w-80">

   <h2><span><b> Disability Evaluation Under Social Security<br>
        <br>
        102.00 Special Senses and Speech - Childhood<br>
        <br>
        </b></span></h2>

                            <!--GRID-->
					<div class="grid">

                         <!--FIRST INNER COLUMN-->
					<article class="cell w-100 m-w-20">

<u><b>Section</b></u><br><br>
<br>
			    <a href="#102_01" title=" 102.01 Category of Impairments, Special Sense Organs"><b>102.01 </b>
              <br>Category of Impairments, Special Sense Organs</a><br>
				<br>
			  
			  
			<a href="#102_02" title=" 102.02 Impairments of Central Visual Acuity"><b> 102.02</b><br>
			Loss of Visual Acuity</a>
			<br>
			<br>


            <a href="#102_03"><strong>102.03</strong><br>
            Contraction of<br>
            the visual field in<br>
            the better eye</a><br>
            <br>
			
            <a href="#102_04"><strong>102.04</strong><br>
            Loss of visual efficiency<br>
              </a><br>
		      <b><a href="#102_10">102.10</a></b><a href="#102_10"><br>
Hearing loss not treated with cochlear implantation</a><br>
<a href="#102_11" title=" 102.08 Hearing Impairments"><br>
<strong>102.11</strong><br>
Hearing loss treated with cochlear implantation<br>
	      </a>  
          
                            </article><!--END FIRST INNER COLUMN-->

							<!--SECOND inner COLUMN-->
							<article class="cell w-100 m-w-80">

<p id="102_00"><u><b>102.00 Special Senses 
            and Speech</b></u></p>
<p id="102_00A"><strong>A. <em>How do we evaluate visual disorders?</em></strong></p>
<p id="102_00A1"><strong>1. <em>What are visual disorders?</em> </strong>Visual  disorders are abnormalities of the eye, the optic nerve, the optic tracts, or  the brain that may cause a loss of visual acuity or visual fields. A loss of  visual acuity limits your ability to distinguish detail, read, do fine work, or  perform other age-appropriate activities. A loss of visual fields limits your  ability to perceive visual stimuli in the peripheral extent of vision.</p>
      <p id="102_00A2"><strong>2. <em>How  do we define statutory blindness?</em></strong> Statutory blindness is blindness as defined in sections 216(i)(1) and 1614(a)(2) of the Social Security Act (Act). </p>
      <p id="102_00A2a">a. The Act defines blindness as central visual acuity of 20/200 or less in the better eye with the use of a correcting lens. 
    We use your best-corrected central visual acuity for  distance in the better eye when we determine if this definition is met. 
    (For visual acuity testing requirements, see <a href="#102_00A5" title="Section 102.00 - Subsection A5">102.00A5</a>.)</p>
      <p id="102_00A2b">b. The Act also provides that an eye that has a visual field limitation such that the widest diameter of the visual field subtends an angle no greater than 20 degrees is considered as having a central visual acuity of 20/200 or less. 
    (For visual field testing  requirements, see <a href="#102_00A6" title="Section 102.00 - Subsection A6">102.00A6</a>.)</p>
      <p id="102_00A2c">c. You have statutory blindness only if your visual disorder meets the criteria of <a href="#102_02A" title="Section 102.02 - Subsection A">102.02A</a>,
    <a href="#102_02B" title="Section 102.02 - Subsection B">102.02B</a>, or <a href="#102_03A" title="Section 102.03 - Subsection A">102.03A</a>.
    You do not have statutory blindness if your visual disorder medically equals the criteria of <a href="#102_02A" title="Section 102.02 - Subsection A">102.02A</a>, 
    <a href="#102_02B" title="Section 102.02 - Subsection B">102.02B</a>, or <a href="#102_03A" title="Section 102.03 - Subsection A">102.03A</a>
    or meets or medically equals the criteria of <a href="#102_03B" title="Section 102.03 - Subsection B">102.03B</a>, <a href="#102_03C" title="Section 102.03 - Subsection C">102.03C</a>,
    <a href="#102_04A" title="Section 102.04 - Subsection A">102.04A</a>, or <a href="#102_04B" title="Section 102.04 - Subsection B">102.04B</a> because your disability is based on criteria other than those in the statutory definition of blindness.
</p>
<p>&nbsp;</p>
            <p align="center"><b><a href="#Top" class="seventypercent">Back to Top</a></b> </p>
            <p id="102_00A3"><strong>3. <em>What evidence do we need to establish statutory blindness under title XVI?</em></strong> 
    To establish that you have statutory blindness under title XVI, 
    we need evidence showing only that your central visual acuity in your better eye or your visual field in your better eye meets the criteria in <a href="#102_00A2" title="Section 102.00 - Subsection A2">102.00A2</a>, 
    provided that those measurements are  consistent with the other evidence in your case record. We do not need  documentation of the cause of your blindness. 
    Also, there is no duration requirement for statutory blindness under title&nbsp;XVI 
    (see §§<a href="https://www.ssa.gov/OP_Home/cfr20/416/416-0981.htm" target="_blank" title="Code of Federal Regulations section 416.981">416.981</a>
    and <a href="https://www.ssa.gov/OP_Home/cfr20/416/416-0983.htm" target="_blank" title="Code of Federal Regulations section 416.983">416.983</a> of this chapter).&nbsp;</p>
            <p id="102_00A4"><strong>4.</strong> <em><strong>What evidence do we need to evaluate visual disorders, including those that result in statutory blindness under title II?</strong></em> 
    To evaluate your visual disorder, we usually need a report of an eye examination that includes measurements of your best-corrected central visual acuity 
    (see <a href="#102_00A5" title="Section 102.00 - Subsection A5">102.00A5</a>) or the extent of your visual fields (see <a href="#102_00A6" title="Section 102.00 - Subsection A6">102.00A6</a>),
    as appropriate. If you have visual acuity or visual field loss, we need documentation of the cause of the loss.
    A standard eye examination will usually indicate the cause of any visual acuity loss. A standard eye examination can also indicate the cause of some types of visual field deficits.
    Some disorders, such as cortical visual disorders, may result in abnormalities that do not appear on a standard eye examination.
    If the standard eye examination does not indicate the cause of your vision loss, we will request the information used to establish the presence of your visual disorder.
    If your visual disorder does not satisfy the criteria in <a href="#102_02" title="Section 102.02">102.02</a>,
    <a href="#102_03" title="Section 102.03">102.03</a>, or <a href="#102_04" title="Section 102.04">102.04</a>, we will request a description of how your visual disorder affects your ability to function.
</p>
<p align="center"><b><a href="#Top" class="seventypercent">Back to Top</a></b></p>
<p id="102_00A5">5.<em><strong> How do we measure best-corrected visual acuity?</strong></em></p>
            <p id="102_00A5a">a. <em>Visual acuity testing.</em> When we need to measure your best-corrected central visual acuity, which is your optimal visual acuity  attainable with the use of a corrective lens, we use visual acuity testing for  distance that was carried out using Snellen methodology or any other testing  methodology that is comparable to Snellen methodology.</p>
            <p id="102_00A5ai">(i) Your best-corrected central visual acuity for distance is usually measured by determining what you  can see from 20 feet. If your visual acuity is measured for a distance other  than 20 feet, we will convert it to a 20-foot measurement. For example, if your  visual acuity is measured at 10 feet and is reported as 10/40, we will convert  this measurement to 20/80.</p>
            <p id="102_00A5aii">(ii) A visual acuity recorded as CF (counts fingers), HM (hand motion only), LP or LPO (light perception or light perception only), or NLP (no light perception) indicates  that no optical correction will improve your visual acuity. If your central  visual acuity in an eye is recorded as CF, HM, LP or LPO, or NLP, we will  determine that your best-corrected central visual acuity is 20/200 or less in  that eye.</p>
            <p id="102_00A5aiii">(iii) We will not use the results of pinhole testing or automated refraction acuity to determine your best-corrected central visual acuity. These tests provide an estimate of  potential visual acuity but not an actual measurement of your best-corrected  central visual acuity.</p>
            <p id="102_00A5aiv">(iv) Very young children, such as infants and toddlers, cannot participate in testing using Snellen methodology or other comparable testing. If you are unable to participate in  testing using Snellen methodology or other comparable testing due to your young  age, we will consider clinical findings of your fixation and visual-following  behavior. If both these behaviors are absent, we will consider the anatomical  findings or the results of neuroimaging, electroretinogram, or visual evoked  response (VER) testing when this testing has been performed.</p>
<p align="center"><b><a href="#Top" class="seventypercent">Back to Top</a></b> </p>			
            <p id="102_00A5b">b. <em>Other test charts.</em></p>
            <p id="102_00A5bi">(i) Children between the  ages of 3 and 5 often cannot identify the letters on a Snellen or other letter  test chart. Specialists with expertise in assessment of childhood vision use  alternate methods for measuring visual acuity in young children. We consider  alternate methods, for example, the Landolt C test or the tumbling-E test,  which are used to evaluate young children who are unable to participate in  testing using Snellen methodology, to be comparable to testing using Snellen methodology. </p>
            <p id="102_00A5bii">(ii) Most test charts that use Snellen methodology do not have lines that measure visual acuity  between 20/100 and 20/200. Some test charts, such as the Bailey-Lovie or the  Early Treatment Diabetic Retinopathy Study (ETDRS), used mostly in research  settings, have such lines. If your visual acuity is measured with one of these  charts, and you cannot read any of the letters on the 20/100 line, we will  determine that you have statutory blindness based on a visual acuity of 20/200  or less. For example, if your best-corrected central visual acuity for distance  in the better eye is 20/160 using an ETDRS chart, we will find that you have  statutory blindness. Regardless of the type of test chart used, you do not have  statutory blindness if you can read at least one letter on the 20/100 line. For  example, if your best-corrected central visual acuity for distance in the  better eye is 20/125+1 using an ETDRS chart, we will find that you do not have  statutory blindness because you are able to read one letter on the 20/100 line. </p>
            <p id="102_00A5c">c. <em>Testing using a specialized lens.</em> In some instances, you may perform visual acuity testing using a specialized lens, such  as a contact lens. We will use the visual acuity measurements obtained with a  specialized lens only if you have demonstrated the ability to use the  specialized lens on a sustained basis. We will not use visual acuity  measurements obtained with telescopic lenses. </p>
            <p id="102_00A5d">d. <em>Cycloplegic refraction</em> is an examination of the eye performed after  administering cycloplegic eye drops capable of relaxing the ability of the  pupil to become smaller and temporarily paralyzing the focusing muscles. If  your case record contains the results of cycloplegic refraction, we may use the  results to determine your best-corrected central visual acuity. We will not  purchase cycloplegic refraction.</p>
            <p id="102_00A5e">e. <em>VER testing</em> measures your response to visual events and can often detect dysfunction that is undetectable through other types of examinations. 
    If  you have an absent response to VER testing in your better eye, 
    we will determine that your best-corrected central visual acuity is 20/200 or 
    less in that eye and that your visual acuity loss satisfies the criterion in <a href="#102_02A" title="Section 102.02 - Subsection A">102.02A</a> 
    or <a href="#102_02B4" title="Section 102.02 - Subsection B4">102.02B4</a>, as appropriate, when these test results are consistent with the other evidence in your case record. 
    If you have a positive response to VER testing in an eye, we will not use that result to determine your best-corrected central visual acuity in that eye.</p>
            <p align="center"><b><a href="#Top" class="seventypercent">Back to Top</a></b> </p>			
            <p id="102_00A6">6. <strong><em>How do we measure visual fields?</em></strong></p>
            <p id="102_00A6a">a. <em>General.</em> We generally need visual field testing when you have a visual disorder that could result in visual field loss, 
    such as glaucoma, retinitis pigmentosa, or optic neuropathy, or when you  display behaviors that suggest a visual field loss. 
    When we need to measure the extent of your visual field loss, we use visual field testing (also referred to as perimetry) 
    carried out using automated static threshold perimetry performed on an acceptable perimeter. 
    (For perimeter requirements, see <a href="#102_00A9" title="Section 102.00 - Subsection A9">102.00A9</a>.)</p>
            <p id="102_00A6b">b. <em>Automated static threshold perimetry requirements.</em></p>
            <p id="102_00A6bi">(i) The test must use a white size III Goldmann stimulus and a 31.5 apostilb (asb) white background (or a 10 candela per square meter (cd/m<sup>2</sup>) white background). The stimuli  test locations must be no more than 6 degrees apart horizontally or vertically.  Measurements must be reported on standard charts and include a description of  the size and intensity of the test stimulus.</p>
            <p id="102_00A6bii">(ii) We measure the extent of your visual field loss by determining the portion of the visual field  in which you can see a white III4e stimulus. The "III" refers to the  standard Goldmann test stimulus size III (4 mm<sup>2</sup>), and the  "4e" refers to the standard Goldmann intensity filter (0 decibel (dB)  attenuation, which allows presentation of the maximum luminance) used to  determine the intensity of the stimulus.</p>
            <p id="102_00A6biii">(iii) In automated static threshold perimetry, the intensity of the stimulus varies. The intensity of the  stimulus is expressed in decibels (dB). A perimeter's maximum stimulus  luminance is usually assigned the value 0 dB. We need to determine the dB level  that corresponds to a 4e intensity for the particular perimeter being used. We  will then use the dB printout to determine which points you see at a 4e  intensity level (a "seeing point"). For example:</p>
            <p id="102_00A6biiiA"><em>A.</em> When the maximum stimulus luminance (0 dB stimulus) on an acceptable perimeter is 10,000  asb, a 10 dB stimulus is equivalent to a 4e stimulus. Any point you see at 10  dB or greater is a seeing point.</p>
            <p id="102_00A6biiiB"><em>B.</em> When the maximum stimulus luminance (0 dB stimulus) on an acceptable perimeter is 4,000  asb, a 6 dB stimulus is equivalent to a 4e stimulus. Any point you see at 6 dB  or greater is a seeing point. </p>
            <p id="102_00A6biiiC"><em>C.</em> When the maximum stimulus luminance (0 dB stimulus) on an acceptable perimeter is 1,000  asb, a 0 dB stimulus is equivalent to a 4e stimulus. Any point you see at 0 dB  or greater is a seeing point.</p>
            <p id="102_00A6c">c. <em>Evaluation under <a href="#102_03A" title="Section 102.03 - Subsection A">102.03A</a>.</em> 
                To determine statutory blindness based on  visual field loss in your better eye (<a href="#102_03A" title="Section 102.03 - Subsection A">102.03A</a>),
    we need the results of a visual  field test that measures the central 24 to 30 degrees of your visual field;
    that is, the area measuring 24 to 30 degrees from the point of fixation.
    Acceptable tests include the Humphrey Field Analyzer (HFA) 30–2, HFA 24–2, and  Octopus 32.
</p>
            <p id="102_00A6d">d. <em>Evaluation under <a href="#102_03B" title="Section 102.03 - Subsection B">102.03B</a>.</em> 
    To determine whether your visual field loss meets listing <a href="#102_03B" title="Section 102.03 - Subsection B">102.03B</a>, 
    we use the mean deviation or defect (MD) from  acceptable automated static threshold perimetry that measures the central 30  degrees of the visual field. 
    MD is the average sensitivity deviation from  normal values for all measured visual field locations. When using results from  HFA tests, 
    which report the MD as a negative number, we use the absolute value  of the MD to determine whether your visual field loss meets listing <a href="#102_03B" title="Section 102.03 - Subsection B">102.03B</a>.
    We cannot use tests that do not measure the central 30 degrees of the visual  field, such as the HFA 24–2,
    to determine if your impairment meets or medically equals <a href="#102_03B" title="Section 102.03 - Subsection B">102.03B</a>.
</p>
            <p id="102_00A6e">e. <em>Other types of perimetry.</em> 
    If your case record contains visual field  measurements obtained using manual or automated kinetic perimetry, 
    such as Goldmann perimetry or the HFA "SSA Test Kinetic," we can generally use these results if the kinetic test was performed using a white III4e stimulus projected on a white 31.5 asb 
    (10 cd/m<sup>2</sup>) background.  Automated kinetic perimetry, such as the HFA "SSA Test Kinetic," does not detect limitations in the central visual field because testing along a 
    meridian stops when you see the stimulus. If your visual disorder has progressed to the point at which it is likely to result in a significant limitation in the central visual field, 
    such as a scotoma (see <a href="#102_00A6h" title="Section 102.00 - Subsection A6h">102.00A6h</a>), we will not use <em>automated</em> kinetic perimetry to determine the extent of your visual field loss.
    Instead, we will determine the extent of your visual field loss using automated static threshold  perimetry or manual kinetic perimetry.
</p>
            <p id="102_00A6f">f. <em>Screening tests.</em> We will not use the results of visual field screening tests, such as confrontation tests, tangent screen tests, 
    or automated static screening tests, to determine that your  impairment meets or medically equals a listing, or functionally equals the listings. 
    We can consider normal results from visual field screening tests to  determine whether your visual disorder is severe when these test results are consistent with the other evidence in your case record. 
    (See <a href="https://www.ssa.gov/OP_Home/cfr20/416/416-0924.htm#c" target="_blank" title="Code of Federal Regulations section 416.924 - Subsection c">§416.924(c)</a> of  this chapter.)
    We will not consider normal test results to be consistent with the other evidence if the clinical findings indicate that your visual disorder has progressed
    to the point that it is likely to cause visual field loss, or you have a history of an operative procedure for retinal detachment.
</p>
            <p id="102_00A6g">g. <em>Use of corrective lenses</em><em>.</em> You must not wear eyeglasses during visual field testing because they limit your field of vision.  You may wear contact lenses to correct your visual acuity during the visual  field test to obtain the most accurate visual field measurements. For this  single purpose, you do not need to demonstrate that you have the ability to use  the contact lenses on a sustained basis.</p>
            <p id="102_00A6h">h. <em>Scotoma.</em> A scotoma is a field defect or non-seeing area (also  referred to as a “blind spot”) in the visual field surrounded by a normal field  or seeing area. When we measure your visual field, we subtract the length of  any scotoma, other than the normal blind spot, from the overall length of any  diameter on which it falls. </p>
<p align="center" id="102_00A7"><b><a href="#Top" class="seventypercent">Back to Top</a></b> </p>			
            <p>7. <strong><em>How do we determine your visual acuity efficiency, visual field efficiency, and visual efficiency?</em></strong></p>
            <p id="102_00A7a">a. <em>General.</em> <em>Visual efficiency</em>,  a calculated value of your remaining visual function, is the combination of  your <em>visual acuity efficiency</em> and  your <em>visual field efficiency</em> expressed as a percentage.</p>
            <p id="102_00A7b">b. <em>Visual acuity  efficiency.</em> Visual acuity  efficiency is a percentage that corresponds to the best-corrected central  visual acuity for distance in your better eye. See Table 1.</p>
            <p align="center"><strong>Table 1 - Visual Acuity  Efficiency</strong></p>
<table class="table table-bordered table-striped">
              <tbody><tr>
                <td width="56%" colspan="2"><p align="center"><strong>Snellen best-corrected central visual acuity for    distance</strong></p></td>
                <td width="43%" rowspan="2"><p align="center"><strong>Visual acuity efficiency (%)</strong><br>
                  <strong>(102.04A)</strong></p></td>
              </tr>
              <tr>
                <td width="27%"><p align="center"><strong>English</strong></p></td>
                <td width="28%"><p align="center"><strong>Metric</strong></p></td>
              </tr>
              <tr>
                <td width="27%"><p align="center">20/16</p></td>
                <td width="28%"><p align="center">6/5</p></td>
                <td width="43%"><p align="center">100</p></td>
              </tr>
              <tr>
                <td width="27%"><p align="center">20/20</p></td>
                <td width="28%"><p align="center">6/6</p></td>
                <td width="43%"><p align="center">100</p></td>
              </tr>
              <tr>
                <td width="27%"><p align="center">20/25</p></td>
                <td width="28%"><p align="center">6/7.5</p></td>
                <td width="43%"><p align="center">95</p></td>
              </tr>
              <tr>
                <td width="27%"><p align="center">20/30</p></td>
                <td width="28%"><p align="center">6/9</p></td>
                <td width="43%"><p align="center">90</p></td>
              </tr>
              <tr>
                <td width="27%"><p align="center">20/40</p></td>
                <td width="28%"><p align="center">6/12</p></td>
                <td width="43%"><p align="center">85</p></td>
              </tr>
              <tr>
                <td width="27%"><p align="center">20/50</p></td>
                <td width="28%"><p align="center">6/15</p></td>
                <td width="43%"><p align="center">75</p></td>
              </tr>
              <tr>
                <td width="27%"><p align="center">20/60</p></td>
                <td width="28%"><p align="center">6/18</p></td>
                <td width="43%"><p align="center">70</p></td>
              </tr>
              <tr>
                <td width="27%"><p align="center">20/70</p></td>
                <td width="28%"><p align="center">6/21</p></td>
                <td width="43%"><p align="center">65</p></td>
              </tr>
              <tr>
                <td width="27%"><p align="center">20/80</p></td>
                <td width="28%"><p align="center">6/24</p></td>
                <td width="43%"><p align="center">60</p></td>
              </tr>
              <tr>
                <td width="27%"><p align="center">20/100</p></td>
                <td width="28%"><p align="center">6/30</p></td>
                <td width="43%"><p align="center">50</p></td>
              </tr>
            </tbody></table>
            <p id="102_00A7c">c. <em>Visual field  efficiency.</em> Visual field  efficiency is a percentage that corresponds to the visual field in your better  eye. Under 102.03C, we require kinetic perimetry to determine your visual field  efficiency percentage. We calculate the visual field efficiency  percentage by adding the number of degrees you see along the eight principal  meridians found on a visual field chart (0, 45, 90, 135, 180, 225, 270, and  315) in your better eye and dividing by 5. For example, in Figure 1:</p>
              <p id="102_00A7cA"><em>A.</em> The diagram  of the left eye illustrates a visual field, as measured with a III4e stimulus,  contracted to 30 degrees in two meridians (180 and 225) and to 20 degrees in  the remaining six meridians. The visual efficiency percentage of this field is:  (( 2 x 30) + (6 x 20)) / 5 = 36 percent.</p>
            <p id="102_00A7cB"><em>B.</em> The diagram  of the right eye illustrates the extent of a normal visual field as measured  with a III4e stimulus. The sum of the eight principal meridians of this field  is 500 degrees. The visual efficiency percentage of this field is 500 / 5 =  100 percent.</p>
            <p align="center"><strong>Figure 1:</strong></p>
<p><img width="533" height="357" src="../../images/figure1.jpg" alt="http://convert.neevia.com/docs/2e8a599d-fa22-4019-b5fc-39a6d2ecc1d8/EyeDoc2-with%20fields%20(final3)1.jpg"></p>
<p id="102_00A7d">d. <em>Visual efficiency.</em> 
    Under <a href="#102_04A" title="Section 102.04 - Subsection A">102.04A</a>, we calculate the  visual efficiency percentage by multiplying your visual acuity efficiency percentage
    (see <a href="#102_00A7b" title="Section 102.00 - Subsection A7b">102.00A7b</a>) by your visual field efficiency percentage (see <a href="#102_00A7c" title="Section 102.00 - Subsection A7c">102.00A7c</a>) and dividing by 100.
    For example, if your visual acuity efficiency percentage is 75 and your visual field efficiency percentage is 36,
    your visual efficiency percentage is: (75 x 36) / 100 = 27 percent.
</p>
<p id="102_00A8"><strong>8. <em>How do we determine your visual acuity impairment value, visual field impairment value, and visual impairment value?</em></strong><em></em></p>
<p id="102_00A8a">a. <em>General.</em> <em>Visual impairment value</em>, a calculated value of your loss of visual function, is the combination of your <em>visual acuity impairment value</em> and your <em>visual  field impairment value</em>.</p>
<p id="102_00A8b">b. <em>Visual acuity  impairment value.</em> Your visual acuity impairment value corresponds to the  best-corrected central visual acuity for distance in your better eye. See Table  2.&nbsp;</p>
<p align="center"><b><a href="#Top" class="seventypercent">Back to Top</a></b> </p>
<p align="center"><strong>Table 2 - Visual Acuity  Impairment Value</strong></p>
<table class="table table-bordered table-striped">
  <tbody><tr>
    <td width="56%" colspan="2"><p align="center"><strong>Snellen best-corrected central visual acuity for    distance</strong></p></td>
    <td width="43%" rowspan="2"><p align="center"><strong>Visual acuity impairment value</strong><br>
      <strong>(102.04B)</strong></p></td>
  </tr>
  <tr>
    <td width="27%"><p align="center"><strong>English</strong></p></td>
    <td width="28%"><p align="center"><strong>Metric</strong></p></td>
  </tr>
  <tr>
    <td width="27%"><p align="center">20/16</p></td>
    <td width="28%"><p align="center">6/5</p></td>
    <td width="43%"><p align="center">0.00</p></td>
  </tr>
  <tr>
    <td width="27%"><p align="center">20/20</p></td>
    <td width="28%"><p align="center">6/6</p></td>
    <td width="43%"><p align="center">0.00</p></td>
  </tr>
  <tr>
    <td width="27%"><p align="center">20/25</p></td>
    <td width="28%"><p align="center">6/7.5</p></td>
    <td width="43%"><p align="center">0.10</p></td>
  </tr>
  <tr>
    <td width="27%"><p align="center">20/30</p></td>
    <td width="28%"><p align="center">6/9</p></td>
    <td width="43%"><p align="center">0.18</p></td>
  </tr>
  <tr>
    <td width="27%"><p align="center">20/40</p></td>
    <td width="28%"><p align="center">6/12</p></td>
    <td width="43%"><p align="center">0.30</p></td>
  </tr>
  <tr>
    <td width="27%"><p align="center">20/50</p></td>
    <td width="28%"><p align="center">6/15</p></td>
    <td width="43%"><p align="center">0.40</p></td>
  </tr>
  <tr>
    <td width="27%"><p align="center">20/60</p></td>
    <td width="28%"><p align="center">6/18</p></td>
    <td width="43%"><p align="center">0.48</p></td>
  </tr>
  <tr>
    <td width="27%"><p align="center">20/70</p></td>
    <td width="28%"><p align="center">6/21</p></td>
    <td width="43%"><p align="center">0.54</p></td>
  </tr>
  <tr>
    <td width="27%"><p align="center">20/80</p></td>
    <td width="28%"><p align="center">6/24</p></td>
    <td width="43%"><p align="center">0.60</p></td>
  </tr>
  <tr>
    <td width="27%"><p align="center">20/100</p></td>
    <td width="28%"><p align="center">6/30</p></td>
    <td width="43%"><p align="center">0.70</p></td>
  </tr>
</tbody></table>
<p align="center">&nbsp;</p>
<p id="102_00A8c">c. <em>Visual field  impairment value.</em> Your visual  field impairment value corresponds to the visual field in your better eye. Using  the MD from acceptable automated static threshold perimetry, we calculate the  visual field impairment value by dividing the absolute value of the MD by 22.  For example, if your MD on an HFA 30-2 is -16, your visual field impairment  value is: |-16| / 22 = 0.73.</p>
<p id="102_00A8d">d. <em>Visual impairment value.</em> 
    Under <a href="#102_04B" title="Section 102.04 - Subsection B">102.04B</a>, we calculate the visual impairment value by adding your visual acuity impairment value
    (see <a href="#102_00A8b" title="Section 102.00 - Subsection A8b">102.00A8b</a>) and your visual field  impairment value (see <a href="#102_00A8c" title="Section 102.00 - Subsection A8c">102.00A8c</a>).
    For example, if your visual acuity impairment value is 0.48 and your visual field impairment value is 0.73,
    your visual impairment value is: 0.48 + 0.73 = 1.21.
</p>
<p id="102_00A9"><strong>9. <em>What  are our requirements for an acceptable perimeter?</em></strong><em></em> We will use results from automated static threshold perimetry performed on a perimeter that:</p>
<p id="102_00A9a">a.  Uses optical projection to generate the test stimuli.</p>
<p id="102_00A9b">b.  Has an internal normative database for  automatically comparing your performance with that of the general population.</p>
<p id="102_00A9c">c.  Has a statistical analysis package that is able to calculate visual field indices, particularly mean deviation or mean defect.</p>
<p id="102_00A9d">d.  Demonstrates the ability to correctly detect visual field loss and correctly identify normal visual fields.</p>
<p id="102_00A9e">e.  Demonstrates good test-retest reliability.</p>
<p id="102_00A9f">f.  Has undergone clinical validation studies by three  or more independent laboratories with results published in peer-reviewed  ophthalmic journals.</p>
<p align="center"><b><a href="#Top" class="seventypercent">Back to Top</a></b> </p>			
            <p id="102_00B"><em><strong>  B. How do we evaluate hearing loss? </strong></em></p>
            <p id="102_00B1"><em><strong>1.</strong></em> <strong><em>What evidence do we need? </em></strong></p>
            <p id="102_00B1a">a. We need evidence showing that you have a medically determinable impairment that causes your hearing loss and audiometric measurements of the severity of your hearing loss. We generally require  both an otologic examination and audiometric testing to establish that you have  a medically determinable impairment that causes your hearing loss. You should  have this audiometric testing within 2 months of the otologic examination. Once  we have evidence that you have a medically determinable impairment, we can use  the results of later audiometric testing to assess the severity of your hearing  loss without another otologic examination. We will consider your test scores together with any other relevant information we have about your hearing, including information from outside of the test setting.</p>
            <p id="102_00B1b">b. The otologic  examination must be performed by a licensed physician (medical or osteopathic  doctor) or audiologist. It must include your medical history, your description  of how your hearing loss affects you, and the physician’s or audiologist’s  description of the appearance of the external ears (pinnae and external ear  canals), evaluation of the tympanic membranes, and assessment of any middle ear  abnormalities.</p>            
            <p id="102_00B1c">c. Audiometric testing  must be performed by, or under the direct supervision of, a licensed  audiologist or an otolaryngologist.</p>
            <p align="center"><b><a href="#Top" class="seventypercent">Back to Top</a></b> </p>			
            <p id="102_00B2"><strong>2.</strong><strong><em> What audiometric testing do we need when you do not have a cochlear implant? </em></strong></p>
            <p id="102_00B2a">a. <strong>General.</strong> 
    We need either physiologic or behavioral testing (other than screening testing, see <a href="#102_00B2g" title="Section 102.00 - Subsection B2g">102.00B2g</a>) that is appropriate for your age at the time of testing.
    See <a href="#102_00B2c" title="Section 102.00 - Subsection B2c">102.00B2c</a>-<a href="#102_00B2f" title="Section 102.00 - Subsection B2f">102.00B2f</a>.
    We will make every reasonable effort to obtain the results of physiologic testing that has been done; however, we will not purchase such testing.
</p>
            <p id="102_00B2b">b. <strong>Testing requirements.</strong> 
    The testing must be conducted in accordance with the most recently published standards of the American National Standards Institute (ANSI). 
    You must not wear hearing aids during the testing. 
    Additionally, a person described in <a href="#102_00B1c" title="Section 102.00 - Subsection B1c">102.00B1c</a> must perform an otoscopic examination immediately before the audiometric testing.
    (An <strong>otoscopic examination</strong> provides a description of the appearance of your external ear canals and an evaluation of the tympanic membranes.
    In these rules, we use the term to include otoscopic examinations performed by physicians and otoscopic inspections performed by audiologists and others.)
    The otoscopic examination must show that there are no conditions that would prevent valid audiometric testing, such as fluid in the ear, ear infection, or obstruction in an ear canal.
    The person performing the test should also report on any other factors, such as your ability to maintain attention, that can affect the interpretation of the test results.
</p>
            <p id="102_00B2c">c. Children from birth to the attainment of age 6 months. </p>
            <p id="102_00B2ci">(i) We need physiologic testing, such as auditory brainstem response (ABR) testing. </p>
            <p id="102_00B2cii">(ii) To determine whether your hearing loss meets <a href="#102_10A" title="Section 102.10 - Subsection A">102.10A</a>, 
    we will average your hearing thresholds at 500, 1000, 2000, and 4000 Hertz (Hz). 
    If you do not have a response at a particular frequency, 
    we will use a threshold of 5 decibels (dB) over the limit of the audiometer. </p>
            <p id="102_00B2d">d. Children from age 6 months to the attainment of age 2. </p>
            <p id="102_00B2di">(i) We need air conduction thresholds determined by a behavioral assessment, usually visual reinforcement audiometry (VRA). We can use ABR testing if the behavioral assessment cannot be completed or if the results are inconclusive or unreliable. </p>
            <p id="102_00B2dii">(ii) To determine whether your hearing loss meets <a href="#102_10A" title="Section 102.10 - Subsection A">102.10A</a>, 
    we will average your hearing thresholds at 500, 1000, 2000, and 4000 Hz. 
    If you do not have a response at a particular frequency, we will use a threshold of 5 dB over the limit of the audiometer. </p>
            <p id="102_00B2diii">(iii) For this age group, behavioral assessments are often performed in a sound field, and each ear is not tested separately. 
    If each ear is not tested separately, we will consider the test results to represent the hearing in the better ear. </p>
            <p id="102_00B2e">e. Children from age 2 to the attainment of age 5. </p>
            <p align="center"><b><a href="#Top" class="seventypercent">Back to Top</a></b> </p>			
            <p id="102_00B2ei"><strong></strong>(i) We need air conduction thresholds determined by a behavioral assessment, such as conditioned play audiometry (CPA), tangible or visually reinforced operant conditioning audiometry (TROCA, VROCA), or VRA. If you have had ABR testing, we can use the results of that testing if the behavioral assessment cannot be completed or the results are inconclusive or unreliable. </p>
            <p id="102_00B2eii">(ii) To determine whether your hearing loss meets <a href="#102_10A" title="Section 102.10 - Subsection A">102.10A</a>, 
    we will average your hearing thresholds at 500, 1000, 2000, and 4000 Hz. 
    If you do not have a response at a particular frequency, we will use a threshold of 5 dB over the limit of the audiometer. </p>
            <p id="102_00B2eiii">(iii) For this age group, behavioral assessments are often performed in a sound field and each ear is not tested separately. If each ear is not tested separately, we will consider the test results to represent the hearing in the better ear. </p>
            <p id="102_00B2f">f. Children from age 5 to the attainment of age 18. </p>
            <p id="102_00B2fi">(i) We generally need pure tone air conduction and bone conduction testing, speech reception threshold (SRT) testing (also referred to as "spondee threshold'' or "ST'' testing), and word recognition testing (also referred to as "word discrimination'' or "speech discrimination'' testing). This testing must be conducted in a sound-treated booth or room and must be in accordance with the most recently published ANSI standards. Each ear must be tested separately. </p>
            <p id="102_00B2fii">(ii) To determine whether your hearing loss meets the air and bone 
    conduction criterion in <a href="#102_10B1" title="Section 102.10 - Subsection B1">102.10B1</a> or <a href="#102_10B3" title="Section 102.10 - Subsection B3">102.10B3</a>,
    we will average your hearing thresholds at 500, 1000, 2000, and 4000 Hz.
    If you do not have a response at a particular frequency, we will use a threshold of 5 dB over the limit of the audiometer.
</p>
            <p id="102_00B2fiii">(iii) The SRT is the minimum dB level required for you to recognize 50 percent of the words on a standard list of spondee words. (Spondee words are two-syllable words that have equal stress on each syllable.) The SRT is usually within 10 dB of the average pure tone air conduction hearing thresholds at 500, 1000, and 2000 Hz. If the SRT is not within 10 dB of the average pure tone air conduction threshold, the reason for the discrepancy must be documented. If we cannot determine that there is a medical basis for the discrepancy, we will not use the results of the testing to determine whether your hearing loss meets a listing. </p>
            <p id="102_00B2fiv">(iv) Word recognition testing determines your ability to recognize an age-appropriate, standardized list of phonetically balanced monosyllabic words in the absence of any visual cues. This testing must be performed in quiet. The list may be recorded or presented live, but in either case, the words should be presented at a level of amplification that will measure your maximum ability to discriminate words, usually 35 to 40 dB above your SRT. However, the amplification level used in the testing must be medically appropriate, and you must be able to tolerate it. If you cannot be tested at 35 to 40 dB above your SRT, the person who performs the test should report your word recognition testing score at your highest comfortable level of amplification. </p>
            <p id="102_00B2g">&gt;g. <strong>Screening testing.</strong> Physiologic testing, such as ABR and otoacoustic emissions (OAE), 
    and pure tone testing can be used as hearing screening tests. 
    We will not use these tests to determine that your hearing loss meets or medically equals a listing, or to assess functional limitations due to your hearing loss, when they are used only as screening tests. 
    We can consider normal results from hearing screening tests to determine that your hearing loss is not "severe'' when these test results are consistent with the other evidence in your case record. 
    See Sec. <a href="https://www.ssa.gov/OP_Home/cfr20/416/416-0924.htm#c" target="_blank" title="Code of Federal Regulations section 416.924 - Subsection c">416.924(c)</a>. </p>
            <p id="102_00B3"><strong>3.</strong><strong><em>What audiometric testing do we need when you have a cochlear implant? </em></strong></p>
            <p id="102_00B3a">a. If you have a cochlear implant, we will consider you to be disabled until age 5, or for 1 year after initial implantation, whichever is later. </p>
            <p id="102_00B3b">b. After that period, we need word recognition testing performed with any age-appropriate version of the Hearing in Noise Test 
    (HINT) or the Hearing in Noise Test for Children (HINT-C) to determine whether your impairment meets <a href="#102_11B" title="Section 102.11 - Subsection B">102.11B</a>.
    This testing must be conducted in quiet in a sound field. Your implant must be functioning properly and adjusted to your normal settings. The sentences should be presented at 60 dB HL (Hearing Level) and without any visual cues.
</p>
            <p id="102_00B4"><strong>4.</strong><strong><em>  How do we evaluate your word recognition ability if you are not fluent in English? </em></strong></p>
            <p> If you are not fluent in English, you should have word recognition testing using an appropriate word list for the language in which you are most fluent. 
    The person conducting the test should be fluent in the language used for the test. If there is no appropriate word list or no person who is fluent in the language and qualified to perform the test, 
    it may not be possible to measure your word recognition ability. If your word recognition ability cannot be measured, 
    your hearing loss cannot meet <a href="#102_10B2" title="Section 102.10 - Subsection B2">102.10B2</a> or <a href="#102_11B" title="Section 102.11 - Subsection B">102.11B</a>.
    Instead, we will consider the facts of your case to determine whether you have difficulty understanding words in the language in which you are most fluent,
    and if so, whether that degree of difficulty medically equals <a href="#102_10B2" title="Section 102.10 - Subsection B2">102.10B2</a> or <a href="#102_11B" title="Section 102.11 - Subsection B">102.11B</a>.
    For example, we will consider how you interact with family members, interpreters,
    and other persons who speak the language in which you are most fluent.
</p>
            <p id="102_00B5"><strong>5.</strong><strong><em> What do we mean by a marked limitation in speech or language as used in <a href="#102_10B3" title="Section 102.10 - Subsection B3">102.10B3</a>? </em></strong></p>
            <p id="102_00B5a">a. We will consider you to have a marked limitation in speech if: </p>
            <p id="102_00B5ai">(i) Entire phrases or sentences in your conversation are intelligible to unfamiliar listeners at least 50 percent (half) of the time but no more than 67 percent (two-thirds) of the time on your first attempt; and </p>
            <p id="102_00B5aii">(ii) Your sound production or phonological patterns (the ways in which you combine speech sounds) are atypical for your age. </p>
            <p id="102_00B5b">b. We will consider you to have a marked limitation in language when your current and valid test score on an appropriate comprehensive, 
    standardized test of overall language functioning is at least two standard deviations below the mean. 
    In addition, the evidence of your daily communication functioning must be consistent with your test score. If you are not fluent in English, it may not be possible to test your language performance. 
    If we cannot test your language performance, your hearing loss cannot meet <a href="#102_10B3" title="Section 102.10 - Subsection B3">102.10B3</a>.
    Instead, we will consider the facts of your case to determine whether your hearing loss medically equals <a href="#102_10B3" title="Section 102.10 - Subsection B3">102.10B3</a>.
</p>
            <!--<p><em><strong><a name="102_00C" id="102_00C"></a> C. How do we evaluate impairments that do not meet one of the special senses and speech listings? </strong></em></p>
            <p><a name="102_00C1" id="102_00C1"></a> 1. These listings are only examples of common special senses and speech disorders that we consider severe enough to result in 
    marked and severe functional limitations. &nbsp;If your impairment(s) does not meet the criteria of any of these listings, 
    we must also consider whether you have an impairment(s) that satisfies the criteria of a listing in another body system. </p>
            <p><a name="102_00C2" id="102_00C2"></a> 2. If you have a medically determinable impairment(s) that does not meet a listing, 
    we will determine whether the impairment(s) medically equals a listing or functionally equals the listings. 
    &nbsp;(See &sect;&sect; <a href="https://www.ssa.gov/OP_Home/cfr20/416/416-0926.htm" target="_blank" title="Code of Federal Regulations section 416.926">416.926</a> 
    and <a href="https://www.ssa.gov/OP_Home/cfr20/416/416-0926a.htm" target="_blank" title="Code of Federal Regulations section 416.926 - Subsection a">416.926a</a>.) 
    &nbsp;We use the rules in &sect; <a href="https://www.ssa.gov/OP_Home/cfr20/416/416-0994a.htm" target="_blank" title="Code of Federal Regulations section 416.994 - Subsection a">416.994a</a> when we decide whether you continue to be disabled. </p>-->
    
            <p id="102_01"><strong> 102.01 Category of Impairments, Special Senses and Speech</strong></p>
            <p id="102_02"><strong><em> 102.02</em></strong><em><strong> Loss of central visual acuity.</strong></em></p>
            <p id="102_02A"><strong>A.</strong> Remaining vision in the better eye after best correction is 20/200 or less.</p>
            <p>OR</p>
            <p id="102_02B"><strong>B.</strong> An inability to participate in visual acuity  testing using Snellen methodology or other comparable testing, clinical findings that fixation and visual-following behavior are absent in the better  eye, and one of the following:</p>
            <p id="102_02B1">1. Abnormal anatomical findings indicating a visual acuity of 20/200 or less in the better eye (such as the presence of Stage III or worse retinopathy of prematurity despite  surgery, hypoplasia of the optic nerve, albinism with macular aplasia, or  bilateral optic atrophy); or</p>
            <p id="102_02B2">2. Abnormal neuroimaging documenting damage to the cerebral cortex which would be expected to prevent the development of a visual acuity better than 20/200 in the better eye (such  as neuroimaging showing bilateral encephalomyelitis or bilateral  encephalomalacia); or</p>
            <p id="102_02B3">3. Abnormal electroretinogram documenting the presence of Leber’s congenital amaurosis or achromatopsia in the better eye; or</p>
            <p id="102_02B4">4. An absent response to VER testing in the better eye.</p>
<p id="102_03"><strong><em> 102.03 Contraction of the visual field in the better eye, </em></strong><strong> with:</strong></p>
            <p id="102_03A"><strong>A.</strong> The widest diameter subtending an angle around the point of fixation no greater than 20 degrees.</p>
            <p>OR</p>
            <p id="102_03B"><strong>B.</strong> An MD of 22 decibels or greater, determined by automated static threshold perimetry that measures the central 30 degrees of the visual field 
            (see <a href="#102_00A6d" title="Section 102.00 - Subsection A6d">102.00A6d</a>).</p>
            <p>OR</p>
            <p id="102_03C"><strong>C.</strong> A visual field efficiency of 20 percent or less,  determined by kinetic perimetry 
    (see <a href="#102_00A7c" title="Section 102.00 - Subsection A7c">102.00A7c</a>).</p>
<p id="102_04"><strong><em> 102.04 Loss ofvisual efficiency, or visual impairment, in the better eye</em></strong><strong>:</strong></p>
<p id="102_04A">A. A visual efficiency percentage of 20 or less after best correction (see <a href="#102_00A7d" title="Section 102.00 - Subsection A7d">102.00A7d</a>).</p>
<p>OR</p>
<p id="102_04B">B. A visual impairment value of 1.00 or greater after best correction (see <a href="#102_00A8d" title="Section 102.00 - Subsection A8d">102.00A8d</a>).</p>
<p id="102_10"><strong><em> 102.10&nbsp; </em></strong><strong><em> Hearing loss not treated with cochlear implantation. </em></strong></p>
            <p id="102_10A"><strong> A.&nbsp;</strong> For children from birth to the attainment of age 5, 
    an average air conduction hearing threshold of 50 decibels or greater in the better ear (see <a href="#102_00B2" title="Section 102.00 - Subsection B2">102.00B2</a>). </p>
            <p><strong> OR </strong></p>
            <p id="102_10B"><strong> B</strong>. For children from age 5 to the attainment of age 18: </p>
            <p id="102_10B1">1. An average air conduction hearing threshold of 70 decibels or greater in the better ear and an average bone conduction hearing threshold of 
    40 decibels or greater in the better ear (see <a href="#102_00B2f" title="Section 102.00 - Subsection B2f">102.00B2f</a>); or </p>
            <p id="102_10B2">2. A word recognition score of 40 percent or less in the better ear determined using a standardized list of phonetically balanced monosyllabic words 
    (see <a href="#102_00B2f" title="Section 102.00 - Subsection B2f">102.00B2f</a>); or </p>
            <p id="102_10B3">3. An average air conduction hearing threshold of 50 decibels or greater in the better ear and a marked limitation in speech or language 
    (see <a href="#102_00B2f" title="Section 102.00 - Subsection B2f">102.00B2f</a> and <a href="#102_00B5" title="Section 102.00 - Subsection B5">102.00B5</a>). </p>
            <p id="102_11"><strong><em>102.11&nbsp;&nbsp;&nbsp;&nbsp;</em></strong><strong><em>Hearing loss treated with cochlear implantation. </em></strong></p>
            <p id="102_11A"><strong>A.&nbsp;</strong> Consider under a disability until the attainment of age 5 or for 1 year after initial implantation, whichever is later. </p>
            <p><strong> OR </strong></p>
            <p id="102_11B"><strong>B.&nbsp;</strong> Upon the attainment of age 5 or 1 year after initial implantation, whichever is later, 
    a word recognition score of 60 percent or less determined using the HINT or the HINT-C (see <a href="#102_00B3b" title="Section 102.00 - Subsection B3b">102.00B3b</a>). </p>
            <p align="center"><b><a href="#Top" class="seventypercent">Back to Top</a></b> </p>			

 </article><!-- END SECOND INNER COLUMN -->
 
 </div><!-- END GRID-->

</article><!-- END SECOND COLUMN -->

</div><!-- END GRID-->

    </section>
  </main>
  <!-- FOOTER -->
  <ssa-footer class="print-dn"></ssa-footer><script src="https://www.ssa.gov/legacy/components/dist/ssa-footer.js"></script>
  <!-- SCRIPTS -->
  <script src="/framework/js/ssa.firefly.body.js"></script><a class="js-btt" href="#" title="Back to Top"></a>


</body></html>